Two neurologic facets of CTLA4-related haploinsufficiency
Open Access
- 1 July 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology Neuroimmunology & Neuroinflammation
Abstract
Objective To describe the clinical and radiologic neurologic characteristics of patients with cytotoxic T-lymphocyte antigen-4 (CTLA4) haploinsufficiency. Methods Three patients from 2 families had neurologic manifestations in the context of CTLA4 haploinsufficiency. Their clinical and MRI findings are presented. Results A 16-year-old boy with a previous diagnosis of combined immunodeficiency presented with severe recurrent episodes of headaches, motor deficit, and seizures associated with waxing and waning gadolinium-enhancing FLAIR cortical/juxtacortical hyperintensities. His sister, who also had combined immunodeficiency, had a brain MRI when she was aged 13 years due to recent headaches and transient right hemianopsia. It revealed a gadolinium-enhancing left occipital white matter hyperintensity. Another 49-year-old woman had progressive visual loss and cerebellar ataxia in the context of recurrent pulmonary infections. All 3 patients were found to have inherited CTLA4 haploinsufficiency. Patient 1's general condition and neurologic manifestations were completely controlled with abatacept (CTLA4-Ig). Conclusions These cases suggest that in addition to the variable clinical penetrance and wide spectrum of CTLA4 haploinsufficiency, its neurologic spectrum is broad, ranging from recurrent tumefactive lesions to progressive deficits including cerebellar ataxia and optic atrophy with leukoencephalopathy. These phenotypes must be recognized, and should lead to a complete immunologic workup, because potentially effective targeted immunotherapy exists.Keywords
This publication has 10 references indexed in Scilit:
- Pitfalls of immunotherapy: lessons from a patient with CTLA-4 haploinsufficiencyAllergy, Asthma & Clinical Immunology, 2018
- Clinical Challenges: Identification of Patients With Novel Primary Immunodeficiency SyndromesJournal of Pediatric Hematology/Oncology, 2018
- Treatment of Intracerebral Lesions with Abatacept in a CTLA4-Haploinsufficient PatientJournal of Clinical Immunology, 2018
- Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjectsJournal of Allergy and Clinical Immunology, 2018
- Adult-onset genetic leukoencephalopathies: A MRI pattern-based approach in a comprehensive study of 154 patientsBrain, 2014
- Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutationsNature Medicine, 2014
- Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4Science, 2014
- Understanding the CD28/CTLA-4 (CD152) Pathway and Its Implications for Costimulatory BlockadeAmerican Journal of Transplantation, 2014
- MRI pattern approach of adult-onset inherited leukoencephalopathiesNeurology Clinical Practice, 2014
- The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responsesNature Reviews Immunology, 2011